Pharmaceutical Outsourcing Q2 2024 - 5

APRIL/MAY/JUNE 2024 | VOLUME 25, ISSUE 2
In this Issue
17 | CLINICAL TRIALS
Beat the Clock: How an FSP Model Can
Optimize a Follow-the-Sun Approach in
Clinical Development Functions
Gary Barker, Executive Director, Pharmacovigilance,
Functional Service Partnership Solutions
Richard D'Amato, Executive Director, Biostatistics and Programming,
Functional Service Partnership Solutions
Robert King, Executive Director, Functional Service
Partnership Solutions
Jennifer Erdmann, Senior Director, Centralized Monitoring
Sarah Frost, Senior Director, Medical Writing,
Functional Service Partnership Solutions
George Weir, Senior Director, Clinical Data Management,
Functional Service Partnership Solutions
Rebecca Sagosz, Regulatory Publishing Project Consultant
All with the PPD Clinical Research Business of
Thermo Fisher Scientific
20 | CONTRACT RESEARCH
Elevating Laboratory and Manufacturing Equipment
Health With AI-Predicted Health Score
Sridhar Iyengar, CIO & Founder
Elemental Machines
26 | ROUNDTABLE
Pediatric Dosage Forms
32 | SUPPLY CHAIN
Navigating Trends and Challenges Facing
Pharmaceutical Supply Chains
Thomas P Wilson, Global Contract Manufacturing Leader
Pfizer CentreOne
REGULAR FEATURES
2
6
EDITOR'S MESSAGE
EDITORIAL ADVISORY BOARD
35 HORIZON LINES
38 INDUSTRY NEWS
40 ADVERTISER'S INDEX
FEATURED EVENTS
BIO International Convention
June 3-6 | San Diego, CA
The BIO International Convention is the largest and most
comprehensive event for biotechnology, representing the full
ecosystem of biotech with over 20,000 industry leaders from
across the globe.
Whether you work at a public pharmaceutical company, biotech
startup, academia, non-profits, and government or are a researcher,
business development professional or investor, BIO is where you'll
make valuable connections and build relationships. Our proprietary
BIO One-on-One Partnering™ match-making platform-included
in the Premier Access registration package-allows you to find
potential partners, schedule and accept meetings.
DIA 2024 Global Annual Meeting
June 16-20 | San Diego CA
SPECIAL FEATURES
24 AN INTERVIEW WITH GIANMARCO NEGRISOLI,
FLAMMA USA
For the 60th Anniversary, DIA has served as a navigational
beacon, by providing a neutral and transparent global forum
for the exchange of ideas to further scientific and medical
innovations. Fueled by the alliance of thousands of attendees, the
DIA 2024 Global Annual Meeting (DIA 2024) will hoist the anchor
and steer towards solutions to global and local challenges in the
life sciences community by bringing together stakeholders in
industry, regulators, academics, and patients.
DIA 2024 is the essential compass for igniting healthcare product
development and charting new courses of knowledge. DIA 2024 is
more than a meeting, its where global navigators unite to create
solutions. Thousands will convene to discuss today's most pressing
topics in the life sciences field, propose innovative ways to combat
daily obstacles, and network to create lasting connections. Through
180+ sessions spanning over 13 unique educational tracks, you will
have the opportunity to explore the depths of your field or dive
deep into a new topic of interest.
pharmoutsourcing.com | 5 | April/May/June 2024
http://www.pharmoutsourcing.com
Pharmaceutical Outsourcing Q2 2024

Table of Contents for the Digital Edition of Pharmaceutical Outsourcing Q2 2024
